These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 2843688)
21. Captopril-stimulated renin secretion in the diagnosis of renovascular hypertension. Gaul MK; Linn WD; Mulrow CD Am J Hypertens; 1989 May; 2(5 Pt 1):335-40. PubMed ID: 2655659 [TBL] [Abstract][Full Text] [Related]
22. Response to the captopril test is dependent on baseline renin profile. Gerber LM; Mann SJ; Müller FB; Alderman MH; Pickering TG; Sealey JE; Laragh JH J Hypertens; 1994 Feb; 12(2):173-8. PubMed ID: 8021469 [TBL] [Abstract][Full Text] [Related]
23. An overview of the clinical pharmacology of enalapril. Davies RO; Gomez HJ; Irvin JD; Walker JF Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):215S-229S. PubMed ID: 6099737 [TBL] [Abstract][Full Text] [Related]
24. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects. Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164 [TBL] [Abstract][Full Text] [Related]
25. Study of renovascular hypertension in rats. III. Effects of converting enzyme inhibitor (captopril) on the plasma and renal renin activity in two-kidney goldblatt hypertension in rats. Matsushita K Tokai J Exp Clin Med; 1985 Oct; 10(5):545-9. PubMed ID: 3915608 [TBL] [Abstract][Full Text] [Related]
26. A screening test for renovascular hypertension by means of orally active angiotensin I converting enzyme inhibitor, captopril (SQ 14225). Imai Y; Abe K; Otsuka Y; Sakurai Y; Yoshinaga K Tohoku J Exp Med; 1980 Jul; 131(3):311-2. PubMed ID: 6998048 [TBL] [Abstract][Full Text] [Related]
27. Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat. Ajayi AA; Hockings N; Reid JL Br J Clin Pharmacol; 1986 Apr; 21(4):349-57. PubMed ID: 3011047 [TBL] [Abstract][Full Text] [Related]
28. [Captopril-stimulated plasma renin activity in the diagnosis of renovascular hypertension]. Kutkuhn B; Kaup FG; Torsello G; Grabensee B Dtsch Med Wochenschr; 1988 May; 113(18):719-24. PubMed ID: 2835221 [TBL] [Abstract][Full Text] [Related]
29. Captopril-stimulated renal vein renin in hypertensive patients with or without renal artery stenosis. Tomoda F; Takata M; Ohashi S; Ueno H; Ikeda K; Yasumoto K; Iida H; Sasayama S Am J Hypertens; 1990 Dec; 3(12 Pt 1):918-26. PubMed ID: 2081013 [TBL] [Abstract][Full Text] [Related]
30. [Effect of captopril on renal vein plasma renin ratio--diagnosis and predicting response to surgery in renovascular hypertension]. Takata M; Sugimoto T; Mikawa M; Yoshida K; Iuchi K; Iida H; Mizumura Y; Nakada T; Kawahara Y Nihon Jinzo Gakkai Shi; 1983 Aug; 25(8):1017-26. PubMed ID: 6366302 [No Abstract] [Full Text] [Related]
31. Antihypertensive effect of a renin inhibitor in marmosets with a segmental renal infarction. Neisius D; Wood JM J Hypertens; 1987 Dec; 5(6):721-5. PubMed ID: 2828470 [TBL] [Abstract][Full Text] [Related]
32. [Effect of an oral angiotensin I-converting enzyme inhibitor on blood pressure and renin-angiotensin-aldosterone system before and after nephrectomy in two cases with acute renovascular hypertension]. Irabu N; Nakamura K; Morohashi Y; Murakami S; Kawamura K Nihon Jinzo Gakkai Shi; 1982 Sep; 24(9):1029-39. PubMed ID: 6298493 [No Abstract] [Full Text] [Related]
33. Effect of aging on the renin angiotensin system in patients with renovascular hypertension. Morishita R; Higaki J; Mikami H; Matsukawa N; Ogihara T Methods Find Exp Clin Pharmacol; 1992; 14(1):17-21. PubMed ID: 1619967 [TBL] [Abstract][Full Text] [Related]
34. Norepinephrine overflow and renin pattern of the individual kidney in patients with unilateral renal artery stenosis. Friberg P; Volkmann R; Jensen G; Aurell M Hypertension; 1991 Jun; 17(6 Pt 2):1003-9. PubMed ID: 1646164 [TBL] [Abstract][Full Text] [Related]
35. Regional haemodynamic effects of captopril, enalaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro rats. Muller AF; Gardiner SM; Compton AM; Bennett T Clin Sci (Lond); 1990 Oct; 79(4):393-401. PubMed ID: 2171862 [TBL] [Abstract][Full Text] [Related]
36. Improved diagnosis of unilateral renal artery lesions after captopril administration. Thibonnier M; Joseph A; Sassano P; Guyenne TT; Corvol P; Raynaud A; Seurot M; Gaux JC JAMA; 1984 Jan; 251(1):56-60. PubMed ID: 6361288 [TBL] [Abstract][Full Text] [Related]
37. Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension. Ideishi M; Sasaguri M; Ikeda M; Arakawa K Clin Ther; 1989; 11(4):441-51. PubMed ID: 2550133 [TBL] [Abstract][Full Text] [Related]
38. Effect of enalapril on renin, angiotensin converting enzyme activity, aldosterone and prostaglandins in patients with hypertension. Larochelle P; Gutkowska J; Schiffrin E; Kuchel O; Hamet P; Genest J Clin Invest Med; 1985; 8(3):197-201. PubMed ID: 2994932 [TBL] [Abstract][Full Text] [Related]
39. Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension. Johnston CI; Jackson BJ; Larmour I; Cubella R; Casley D Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):233S-239S, 241S. PubMed ID: 6099738 [TBL] [Abstract][Full Text] [Related]
40. Differentiation between renovascular and essential hypertension by means of changes in single kidney 99mTc-DTPA clearance induced by angiotensin-converting enzyme inhibition. Pedersen EB; Jensen FT; Eiskjaer H; Hansen HH; Jensen JD; Jespersen B; Madsen B; Nielsen HK; Sørensen SS Am J Hypertens; 1989 May; 2(5 Pt 1):323-34. PubMed ID: 2655658 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]